Back to top

Can The Uptrend Continue for Adverum Biotechnologies (ADVM)?

Read MoreHide Full Article

Investors certainly have to be happy with Adverum Biotechnologies, Inc. (ADVM - Free Report) and its short term performance. After all, the stock has jumped by 33.2% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for ADVM?

While we can never know for sure, it is pretty encouraging that estimates for ADVM have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #2 (Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks. You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Companies Verge on Apple-Like Run

Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.

Click to see them right now >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Adverum Biotechnologies, Inc. (ADVM) - free report >>

More from Zacks Tale of the Tape

You May Like